tiprankstipranks
Trending News
More News >
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY

Allergy Therapeutics (AGY) Revenue

Compare
16 Followers

Allergy Therapeutics Revenue

Allergy Therapeutics had a revenue of 21.63M in the quarter ending Jun 30, 2024, with -35.58%. This bring the company's revenue in the last twelve months to 55.20M, Decreased 3.64%. In the fiscal year ending Jun 30, 2024, Allergy Therapeutics had annual revenue of 55.20M with -7.36% growth.
Revenue (ttm)
55.20M
Revenue Growth
4.50%
P/S Ratio
6.00
Revenue/Employee
£90,194
Employees
612
Market Cap
£331.27M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 202455.20M-4.39M-7.36%
Jun 30, 202359.59M-13.18M-18.11%
Jun 30, 202272.77M-11.56M-13.71%
Jun 30, 202184.33M6.13M+7.83%
Jun 30, 202078.20M4.49M+6.09%
Jun 30, 201973.72M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis